New therapeutic indications for botulinum toxins

Movement Disorders

Volumn 19, Issue SUPPL. 8, 2004, Pages

  Cordivari, Carla ^a,b   Misra, V Peter ^a   Catania, Santiago ^a   Lees, Andrew J ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Botulinum toxin; Dystonia; Hyperhidrosis; Hypersalivation; Myoclonus; Pain; Parkinsonism; Tic; Tremor

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; ANTIPARKINSON AGENT;

ARTICLE; BACKACHE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; COSMETIC INDUSTRY; DENTAL CARIES; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; DYSPHAGIA; DYSTONIA; GASTROINTESTINAL DISEASE; GINGIVA DISEASE; HEMATOMA; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; INFECTION; LACRIMAL GLAND DISEASE; MIGRAINE; MOTOR DYSFUNCTION; MUSCLE WEAKNESS; MYOCLONUS; MYOFASCIAL PAIN; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NEUROSURGERY; ORTHOPEDIC SURGERY; PAIN; PATIENT SATISFACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RHINORRHEA; SPASTICITY; STUTTERING; SWEAT GLAND DISEASE; TENSION HEADACHE; TIC; TREATMENT OUTCOME; TREMOR; UROGENITAL TRACT DISEASE; XEROSTOMIA; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; PAROTID GLAND; PLASTIC SURGERY; REVIEW;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DRUG ADMINISTRATION ROUTES; DYSTONIA; HUMANS; PAIN; PAROTID GLAND; SIALORRHEA; SURGERY, PLASTIC; TREMOR;

EID: 3242787237     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20071     Document Type: Article

References (50)

1. Shelley WB, Talanin NY, Shelley ED. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol 1998;38:227-229.
2. Saadia D, Voustianiouk A, Wang AK, Kaufmann H. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Neurology 2001;57:2095-2099.
3. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double- blind trial of botulinum toxin for the treatment of focal hyperhidrosis of the palm. Br J Neurol 1997;136:548-552.
4. Schnider P, Binder M, Kittler H, et al. A randomized, double-blind, placebo-controlled trial of Botulinum toxin for severe axillary hyperhidrosis. Br J Dermatol 1999;140:677-680.
5. Naumann M, Lowe N. A randomized controlled parallel-group study evaluating botulinum toxin type A BOTOX® In the treatment of bilateral axillary hyperhidrosis. JEADV 2000;14:53.
6. Heckmann M, Ceballos-Baumann A, Plewig G. Botulinum Toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488-493.
7. Naumann M, Zellner M, Toyka KV, Reiners K. Treatment of gustatory sweating with botulinum toxin. Ann Neurol 1997;42: 973-975.
8. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B. Recurrant gustatory sweating (Frye syndrome after intracutaneous injections of botulinum toxin type A. Arch Otolaryngol Head Neck Surg 1999;125:282-286.
9. Keegan DJ, Geerling G, Lee JP, Blake G, Collin JR, Plant GT. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol 2002;86:43-46.
10. Rohrbach S, Laskawi R. Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec 2001;63:382-384.
11. Bhatia KP, Münchau A, Brown P. Botulinum toxin is a useful treatment in extensive drooling of saliva. J Neurol Neurosurg Psychiatry 1999;67:697.
12. Jost WH. Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 1999;14:1057-1059.
13. O'Sullivan JD, Bhatia KP, Lees AJ. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;55:606-607.
14. Pal PK, Calne DB, Calnes S, Tsui JKC. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54:244-247.
15. Porta M, Gamba M, Bertacchi G, Vaj P. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry. 2001; 70:538-540.
16. Friedman A, Potuska A. Botulinum toxin for treatment of parkinsonian sialorrhea. Neurol Neurochir Pol 2001;35:23-27.
17. Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreels FJ. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 2001;160:509-512.
18. Giess R, Naumann M, Werner E, Rieman R, Beck M, Puls I, Reiners C, Toyka KV. Injections of Botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-123.
19. Suskind DL, Tilton A. Clinical study of botulinum A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73-81.
20. Ellis M, Laskawi R, Rohrbach-Volland S, Arglebe C, Beuche W. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope. 2002; 112:82-86.
21. Winterholler MG, Erbguth FJ, Wolf S, Kat S. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. J Neurol Neurosurg Psychiatry. 2001;70: 417-418.
22. Brin MF, Lyons KE, Doucette J, et al. A randomized double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001;56:1523-1528.
23. Jankovic J, Schwart K, Clemence W, et al. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996; 11:250-256.
24. Wissel J Masuhr F, Schelosky L, et al. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Mov Disord 1997;12:722-726.
25. Jemieson DRS, Mann C, O'Reilly B, et al. Ear clicks in palatal tremor cause by activity of the levator veli palatini. Neurology 1996;6:1168-1169.
26. Deuschl G, Lohle E, Toro C, Hallett M, Lebovics RS. Botulinum toxin treatment of palatal tremor (myoclonus). In: Jankovic J, Hallet M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. p 567-576.
27. Stager SV, Ludlow CL. Responses of stutterers and vocal tremor patients to treatment with botulinum toxin. In: Jankovic J, Hallet M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. p 481-490.
28. Giladi N, Gurevich T, Shabtai H, Paleacu D, Simon ES. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 2001;248:572-576.
29. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000;57:1190-1193.
30. Trimble MR, Whurr R, Brookes G, et al. Vocal tics in Gilles de la Tourette's syndrome treated with botulinum toxin injections. Mov Disord 1998;13:617-619.
31. Marras C, Andrews D, Sime E, et al Botulinum toxin for simple motor tics: a randomized, double blind, controlled clinical trial. Neurology 2001;56:605-610.
32. Liguori R, Cordivari C, Lugaresi E, Montagna. Botulinum toxin A improves muscle spasms and rigidity in stiff-person syndrome. Mov Disord 1997;12:1060-11063.
33. O'Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain 1996;119:1737-1749.
34. Hufschsmidt A, Mauritz KH. Chronic transformation of muscle in spasticity: a peripheral contribution to increase tone. J Neurol Neurosurg Psychiatry 1985;48:676-685.
35. Cordivari C, Misra VP, Catania S, Lees AJ. Treatment of dystonic clenched fist with botulinum toxin. Mov Disord 2001;16:907-913.
36. Monsivais JJ, Monsivais DB. Botulinum toxin in painful syndromes. Hand Clin 1996;12:787-789.
37. Silberstein SD. Review of botulinum toxin type A and its clinical applications in migraine headache. Expert Opin Pharmacother 2001;2:1649-1654.
38. Freund BJ Schwartz M. Treatment of chronic cervical associated headache with botulinum toxin A: a pilot study. Headache 2000; 40:231-236.
39. Brin MF, Swope DM, Abassi S, et al. Botox for migraine: double blind, placebo controlled, region specific evaluation. Cephalalgia 2000;20:421-422.
40. Criscuolo CM. Interventional approaches to the management of myofacial pain syndrome. Curr Pain Headache Rep 2001;5:407-411.
41. Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases. J Neurosurg. 1998;88:328-330.
42. Fanucci E, Masala S, Sodani G, Varrucciu V, Romagnoli A, Squillaci E, Simonetti G. CT-guided injection of botulinic toxin for percutaneous therapy of piriformis muscle syndrome with preliminary MRI results about denervative process. Eur Radiol 2001;11: 2543-2548.
43. Jordan SE, Ahn SS, Freischlag JA, Gelabert HA, Machleder HI. Selective botulinum chemodenervation of the scalene muscles for treatment of neurogenic thoracic outlet syndrome. Ann Vasc Surg 2000;14:365-369.
44. Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998;338:217-220.
45. Cuillier C, Ducrotte P, Zerbib F, Metman EH, de Looze D, Guillemot F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997;41:87-92.
46. Schurch B, Stohrer M, Kramer G, et al. Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164:692-697.
47. Becker-Wegerich P, Rauch L, Ruzicka T. Botulinum, toxin A in the therapy of mimic facial lines. Clin Exp Dermatol 2001;26:619-630.
48. Blitzer A, Binder WJ, Aviv J, Keen MS, Brin MF. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997;123:389-392.
49. Sposito MM. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck. Aesthetic Plast Surg 2002;26:89-98.
50. To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200.